Bullous pemphigoid (BP) has been repeatedly reported to occur following exposure to the severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study analyzes the molecular mimicrybetween the 180 kDa bullous pemphigoid antigen 2 (BP180) and the SARS-CoV-2 proteome to further ourunderstanding of the molecular link between the BP and the SARS-CoV-2 infection. Results indicate a highdegree of molecular mimicry between BP180, SARS-CoV-2, hCoV-229E and hCoV-NL63.

Peptide sharing between SARS-CoV-2 and Bullous pemphigoid 180

M. Petruzzi
2022-01-01

Abstract

Bullous pemphigoid (BP) has been repeatedly reported to occur following exposure to the severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study analyzes the molecular mimicrybetween the 180 kDa bullous pemphigoid antigen 2 (BP180) and the SARS-CoV-2 proteome to further ourunderstanding of the molecular link between the BP and the SARS-CoV-2 infection. Results indicate a highdegree of molecular mimicry between BP180, SARS-CoV-2, hCoV-229E and hCoV-NL63.
File in questo prodotto:
File Dimensione Formato  
2022 JBRHA Peptide sharing between SARS-CoV-2 and Bullous pemphigoid 180.pdf

non disponibili

Descrizione: Article
Tipologia: Documento in Versione Editoriale
Licenza: Copyright dell'editore
Dimensione 372.68 kB
Formato Adobe PDF
372.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11586/414685
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact